Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

643
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
643
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

354
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
354
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

288
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
288
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

451
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
451

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry.

Journal of molecular biology·2026
Same author

Digital twin of biomacromolecular thermodynamics in cryo-EM data.

Communications chemistry·2026
Same author

Stability-Driven Pose Prediction and Ligand Design via Contact Persistence Analysis from Molecular Dynamics Simulations.

Computational and structural biotechnology journal·2026
Same author

In Silico Regression Modeling and Improved Interpretability To Predict the Transport Inhibitory Activity of Breast Cancer Resistance Protein.

ACS omega·2026
Same author

intDesc-AbMut: A Tool for Describing and Understanding How Antibody Mutations Impact Their Environmental Interactions.

Computational and structural biotechnology journal·2026
Same author

Subset binding enables detection of multimodal patient subgroup patterns and drug target discovery in idiopathic pulmonary fibrosis.

Briefings in bioinformatics·2026
Same journal

ASO-RASAR: A Read-Across Framework for Predicting Antisense Oligonucleotide Gapmer Activity Across Target Genes.

Journal of chemical information and modeling·2026
Same journal

ZHMolTopoRPI: A Commutative Algebra-Driven Deep Learning Framework for Robust RNA-Protein Interaction Prediction.

Journal of chemical information and modeling·2026
Same journal

PP-MAPS: Dynamic Pharmacophore Signatures of Protein-Peptide Interfaces from Molecular Dynamics Trajectories.

Journal of chemical information and modeling·2026
Same journal

Evaluating Molecular Representations for Predicting Cyclodextrin-PFAS Binding Energy with Machine Learning: Domain Transfer and Data Limitations.

Journal of chemical information and modeling·2026
Same journal

Foldify: Web Application for Protein Structure Prediction.

Journal of chemical information and modeling·2026
Same journal

Identification of Noncovalent Small-Molecules from Virtual Screening Toward the Development of Potential KRAS Inhibitors.

Journal of chemical information and modeling·2026
See all related articles
  1. Home
  3. Improving Adme Prediction With Multitask Graph Neural Networks And Assessing Explainability In Lead Optimization.
  1. Home
  3. Improving Adme Prediction With Multitask Graph Neural Networks And Assessing Explainability In Lead Optimization.

Related Experiment Video

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K

Improving ADME Prediction with Multitask Graph Neural Networks and Assessing Explainability in Lead Optimization.

Shoma Ito1, Takuto Koyama1, Shigeyuki Matsumoto1

  • 1Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan.

Journal of Chemical Information and Modeling
|October 22, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

This study introduces an AI model for predicting drug absorption, distribution, metabolism, and excretion (ADME) properties, improving drug development efficiency. The AI model offers interpretable insights into lead optimization, aiding molecular design.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.2K

Related Experiment Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.2K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.2K

Area of Science:

  • Computational chemistry
  • Artificial intelligence in drug discovery
  • Pharmacokinetics

Background:

  • Early assessment of absorption, distribution, metabolism, and excretion (ADME) properties is vital for efficient drug development.
  • Traditional in vivo and in vitro ADME methods are costly and require specialized expertise, posing challenges during lead optimization.
  • Existing in silico ADME prediction methods suffer from limited data, reduced predictive accuracy, and a lack of clear rationale for optimization.

Purpose of the Study:

  • To develop an advanced AI model for predicting ten different ADME parameters.
  • To address the limitations of current in silico methods, including poor predictive performance and lack of interpretability.
  • To provide data-driven insights for molecular design and guide lead optimization strategies.

Main Methods:

  • Utilized a graph neural network architecture incorporating multitask learning and fine-tuning for enhanced predictive performance.
  • Applied the integrated gradients method to quantify feature contributions to ADME predictions.
  • Trained and validated the model on compound data collected before and after lead optimization.

Main Results:

  • The AI model achieved superior performance in predicting seven out of ten ADME parameters compared to conventional methods.
  • Feature importance analysis using integrated gradients provided interpretable insights into the factors influencing ADME properties.
  • Visualizations demonstrated that the model's explanations align with established chemical principles in molecular structure modifications.

Conclusions:

  • The developed AI model shows significant potential for improving the accuracy and interpretability of ADME predictions.
  • Data-driven approaches, augmented by AI, can complement empirical rules in molecular design and drug development.
  • This AI model offers a promising tool for streamlining drug discovery by providing efficient and insightful ADME property evaluation.